Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Lymphoma × Breast × Clear all

Phase

Phase NA 35 Phase 1 27 Phase 1/2 18 Phase 2 15 Phase 3 4 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 34 Other hematologic neoplasm 9 Plasma cell 6 Sarcoma 3 Myeloid 3 Head & Neck 3 Dermatologic 3 Classical hematology 2 CNS 2 Other neoplasm 1 Gastrointestinal 1 Breast 1

Conditions

Breast Neoplasms 168 Triple Negative Breast Neoplasms 23 Lung Neoplasms 15 Pancreatic Neoplasms 10 Ovarian Neoplasms 10 Melanoma 10 Colonic Neoplasms 10 Prostatic Neoplasms 9 Sarcoma 8 Stomach Neoplasms 7 Neoplasms 7 Colorectal Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Carcinoma, Intraductal, Noninfiltrating 6 Urinary Bladder Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Head and Neck Neoplasms 5 Carcinoma, Renal Cell 5 Breast Neoplasms, Male 5 Uterine Cervical Neoplasms 4 Glioblastoma 4 Small Cell Lung Carcinoma 3 Liver Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Hepatocellular 3 Carcinoma, Ductal, Breast 3 Brain Neoplasms 3 Rectal Neoplasms 2 Osteosarcoma 2 Neoplasm, Residual 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05921253 2026-01-26

OU-SCC-NCAN

University of Oklahoma

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡